Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Whitlock, JL; Roeske, JC; Dietz, ML; Straus, CM; Hines, JJ; Horwitz, EP; Reba, RC; Rotmensch, J
   Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview
   INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
   
   J.L. Whitlock et al., "Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview", IND ENG RES, 39(9), 2000, pp. 3135-3139
2. ROTMENSCH J; WHITLOCK JL; SCHWARTZ JL; HINES JJ
   IN-VITRO STUDIES USING THE ALPHA-EMITTER BI-212 - DEVELOPMENT OF THERAPY FOR MICROSCOPIC CARCINOMA
   Radiochimica Acta
   
   J. Rotmensch et al., "IN-VITRO STUDIES USING THE ALPHA-EMITTER BI-212 - DEVELOPMENT OF THERAPY FOR MICROSCOPIC CARCINOMA", Radiochimica Acta, 79(2), 1997, pp. 127-130
3. ROTMENSCH J; WHITLOCK JL; SCHWARTZ JL; HINES JJ; REBA RC; HARPER PV
   IN-VITRO AND IN-VIVO STUDIES ON THE DEVELOPMENT OF THE ALPHA-EMITTINGRADIONUCLIDE BISMUTH-212 FOR INTRAPERITONEAL USE AGAINST MICROSCOPIC OVARIAN-CARCINOMA
   American journal of obstetrics and gynecology
   
   J. Rotmensch et al., "IN-VITRO AND IN-VIVO STUDIES ON THE DEVELOPMENT OF THE ALPHA-EMITTINGRADIONUCLIDE BISMUTH-212 FOR INTRAPERITONEAL USE AGAINST MICROSCOPIC OVARIAN-CARCINOMA", American journal of obstetrics and gynecology, 176(4), 1997, pp. 833-840
4. ROTMENSCH J; WHITLOCK JL; HINES JJ; SCHWARTZ JL; REBA RC; HARPER PV
   USE OF BI-212 IN MICROSCOPIC INTRAPERITONEAL CARCINOMA
   Radiology
   
   J. Rotmensch et al., "USE OF BI-212 IN MICROSCOPIC INTRAPERITONEAL CARCINOMA", Radiology, 201, 1996, pp. 928-928
5. ROTMENSCH J; WHITLOCK JL; CULBERTSON S; ATCHER RW; SCHWARTZ JL
   COMPARISON OF SENSITIVITIES OF CELLS TO X-RAY THERAPY, CHEMOTHERAPY, AND ISOTOPE THERAPY USING A TUMOR SPHEROID MODEL
   Gynecologic oncology
   
   J. Rotmensch et al., "COMPARISON OF SENSITIVITIES OF CELLS TO X-RAY THERAPY, CHEMOTHERAPY, AND ISOTOPE THERAPY USING A TUMOR SPHEROID MODEL", Gynecologic oncology, 55(2), 1994, pp. 290-293